Constance, Germany

Andreas Palmer

This inventor holds 1 USPTO granted patent. Top assignee: Altana Pharma Ag. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Palmer. Retrieved from https://idiyas.com/inventor/andreas-palmer-26kfhe56

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Andreas Palmer in Pharmaceutical Chemistry

Introduction

Andreas Palmer is a notable inventor based in Constance, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that serve as valuable intermediates for drug development.

Latest Patents

One of his key patents is titled "Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives." This invention relates to compounds of a specific formula, where R1, R2, R3, Arom, and PG have defined meanings as indicated in the patent description. These compounds are essential for the preparation of pharmaceutically active compounds, showcasing Palmer's impact on drug formulation.

Career Highlights

Andreas Palmer is associated with Altana Pharma AG, a company known for its focus on innovative pharmaceutical solutions. His work at Altana Pharma AG has allowed him to contribute to the development of new therapeutic agents, enhancing the company's portfolio in the pharmaceutical industry.

Collaborations

He collaborates with Ulrike Nettekoven, a fellow professional in the field. Their partnership exemplifies the collaborative spirit often found in research and development within the pharmaceutical sector.

Conclusion

Andreas Palmer's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the industry. His work continues to influence the development of new and effective pharmaceutical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…